Magle Chemoswed Holding AB (publ) (MAGLE.ST)

SEK 26.4

(-2.22%)

Long Term Debt Summary of Magle Chemoswed Holding AB (publ)

  • Magle Chemoswed Holding AB (publ)'s latest annual long term debt in 2023 was 32.58 Million SEK , down -5.51% from previous year.
  • Magle Chemoswed Holding AB (publ)'s latest quarterly long term debt in 2024 Q2 was 32.58 Million SEK , down 0.0% from previous quarter.
  • Magle Chemoswed Holding AB (publ) reported annual long term debt of 34.48 Million SEK in 2022, up 16.16% from previous year.
  • Magle Chemoswed Holding AB (publ) reported annual long term debt of 29.68 Million SEK in 2021, down -7.92% from previous year.
  • Magle Chemoswed Holding AB (publ) reported quarterly long term debt of 36.82 Million SEK for 2024 Q3, up 13.01% from previous quarter.
  • Magle Chemoswed Holding AB (publ) reported quarterly long term debt of 32.58 Million SEK for 2024 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Magle Chemoswed Holding AB (publ) (2023 - 2017)

Historical Annual Long Term Debt of Magle Chemoswed Holding AB (publ) (2023 - 2017)

Year Long Term Debt Long Term Debt Growth
2023 32.58 Million SEK -5.51%
2022 34.48 Million SEK 16.16%
2021 29.68 Million SEK -7.92%
2020 32.24 Million SEK 578.74%
2019 4.75 Million SEK 1039.09%
2018 417 Thousand SEK -79.98%
2017 2.08 Million SEK 0.0%

Peer Long Term Debt Comparison of Magle Chemoswed Holding AB (publ)

Name Long Term Debt Long Term Debt Difference
Active Biotech AB (publ) 3 Million SEK -986.067%
Biovica International AB (publ) 4.29 Million SEK -658.426%
Cantargia AB (publ) - SEK -Infinity%
CombiGene AB (publ) - SEK -Infinity%
Cyxone AB (publ) 74 Thousand SEK -43929.73%
Diagonal Bio AB (publ) - SEK -Infinity%
Elicera Therapeutics AB (publ) - SEK -Infinity%
ExpreS2ion Biotech Holding AB (publ) 1.43 Million SEK -2168.942%
Fluicell AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Mendus AB (publ) 850 Thousand SEK -3733.176%
Isofol Medical AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Intervacc AB (publ) 142 Thousand SEK -22845.07%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
OncoZenge AB (publ) - SEK -Infinity%
Sprint Bioscience AB (publ) - SEK -Infinity%
Xbrane Biopharma AB (publ) 112.89 Million SEK 71.14%
Lipum AB (publ) 1.76 Million SEK -1750.199%
Alligator Bioscience AB (publ) 7.51 Million SEK -333.502%
Ziccum AB (publ) 286 Thousand SEK -11292.308%
BioArctic AB (publ) 2.15 Million SEK -1414.033%
Genovis AB (publ.) 74.8 Million SEK 56.446%
Camurus AB (publ) 13.61 Million SEK -139.345%
IRLAB Therapeutics AB (publ) 24.51 Million SEK -32.928%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) - SEK -Infinity%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Xspray Pharma AB (publ) 31.94 Million SEK -1.988%
Kancera AB (publ) - SEK -Infinity%
Saniona AB (publ) 65.23 Million SEK 50.057%
Spago Nanomedical AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Abliva AB (publ) 424 Thousand SEK -7584.434%
Karolinska Development AB (publ) - SEK -Infinity%
Amniotics AB (publ) - SEK -Infinity%
2cureX AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK -3158.2%
Calliditas Therapeutics AB (publ) 939.5 Million SEK 96.532%
Hansa Biopharma AB (publ) 844.9 Million SEK 96.144%
Biosergen AB - SEK -Infinity%
QuiaPEG Pharmaceuticals Holding AB (publ) - SEK -Infinity%
Corline Biomedical AB - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Nanologica AB (publ) 136 Thousand SEK -23857.353%
LIDDS AB (publ) - SEK -Infinity%
Egetis Therapeutics AB (publ) 103.4 Million SEK 68.489%
BioInvent International AB (publ) 14.53 Million SEK -124.162%
SynAct Pharma AB 58 Thousand SEK -56075.862%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) 850 Thousand SEK -3733.176%
Alzinova AB (publ) 800 Thousand SEK -3972.75%
Ascelia Pharma AB (publ) 176 Thousand SEK -18412.5%
Oncopeptides AB (publ) 106.48 Million SEK 69.403%
Pila Pharma AB (publ) - SEK -Infinity%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Simris Alg AB (publ) 90.74 Million SEK 64.093%
Diamyd Medical AB (publ) 30.67 Million SEK -6.227%